AstraZeneca Pharmaceuticals LP
The people of AstraZeneca are dedicated to: Discovering, developing, and delivering innovative, meaningful medicines and other healthcare solutions that help enrich the lives of patients, as well as their families and communities. Putting the health of patients first by providing educational programs, resources, and tools designed to help empower and inform. Creating a challenging and rewarding work environment that inspires our employees.
Member in Photos
-

Delaware Bio Winterfest 2012 -

Delaware Bio Winterfest 2012 -

Delaware Bio Winterfest 2012 -

Delaware Bio Winterfest 2012 -

Delaware Bio Winterfest 2012 -

Delaware Bio Winterfest 2012 -

Annual Awards Gala 2011 -

Annual Awards Gala 2011 -

Annual Awards Gala 2011 -

Annual Awards Gala 2011 -

Annual Awards Gala 2011 -

Annual Awards Gala 2011 -

Annual Awards Gala 2011 -

Annual Awards Gala 2011 -

Annual Awards Gala 2008 -

Annual Awards Gala 2008 -

Annual Awards Gala 2008 -

Annual Awards Gala 2010 -

Annual Awards Gala 2010 -

Annual Awards Gala 2010 -

Annual Awards Gala 2010 -

Annual Awards Gala 2010 -

Annual Awards Gala 2010 -

Annual Awards Gala 2010 -

Member Showcase 2009 -

Delaware Bio Winterfest 2009 -

Delaware Bio Winterfest 2009 -

Delaware Bio Winterfest 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009 -

Annual Awards Gala 2009
Member in the News
Jan
21Investing in health of Delaware teens
Astra-Zeneca and United Way of Delaware on Friday launched a cooperative initiative
Mar
13Delaware Jobs: Good teachers, good graduates, good jobs
Delaware creates workforce that is college and career ready
Apr
28AstraZeneca Posts $2.91B First-Quarter Profit
AstraZeneca reported profits of $2.91 billion for the three months ending in March, up from $2.78 billion last year
Mar
15AstraZeneca Recognized as a Top Company for Female Executives
AstraZeneca named one of the top 50 companies for female executives for the third consecutive year
Apr
27Technology provides greater accessibility and convenience to patients, caregivers
AstraZeneca (NYSE:AZN) announced today the launch of “click-to-chat” on CRESTOR.com and PurplePill.com.
Apr
23AstraZeneca Fuels Biotech M&A with $1.3 billion Ardea Buy
AstraZeneca is to buy U.S. company Ardea Biosciences for $1.26 billion, giving it a new gout drug to bolster a weak pipeline in a deal that feeds a wave of M&A in the biotechnology sector.
Contact Information
AstraZeneca Pharmaceuticals LP
1800 concord pikeWilmington, DE 19803
Phone: 302-286-3500
Fax: --
Visit website